Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study
Status:
Completed
Trial end date:
2018-05-18
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate non-inferiority of oral anticoagulant (OAC)
monotherapy to OAC plus single antiplatelet therapy (APT) in patients with atrial
fibrillation (AF) and prior (>12 months) coronary stenting.
Phase:
Phase 4
Details
Lead Sponsor:
Satoshi Shizuta
Collaborators:
Daiichi Sankyo Co., Ltd. Research Institute for Production Development